Botulinum Toxin Market by Product Type and End User - Global Industry Analysis and Forecast to 2023

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.1.1.    Rising Demand for Minimally Invasive Treatment

3.2.1.2.    Expanding Therapeutic Use of Botulinum toxin

3.2.2.  Restraints

3.2.2.1.    Limited Reimbursement Coverage

3.2.2.2.    Misuse as Bioterrorism

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Botulinum Toxin Market, By Product Type

4.1.       Introduction

4.2.       Global Botulinum Toxin Sales, Revenue and Market Share by Product Type (2017-2017)

4.2.1.  Global Botulinum Toxin Sales and Sales Share by Product Type (2017-2017)

4.2.2.  Global Botulinum Toxin Revenue and Revenue Share by Product Type (2017-2017)

4.3.       Botulinum Toxin Market   Assessment and Forecast, By Product Type, 2017-2023

4.4.       Botulinum Toxin Type A

4.4.1.  Market Assessment and Forecast, By Region, 2017-2023($Million)

4.5.       Botulinum Toxin Type B

4.5.1.  Market Assessment and Forecast, By Region, 2017-2023($Million)

5.       Botulinum Toxin Market, By End User

5.1.       Introduction

5.2.       Global Botulinum Toxin Sales, Revenue and Market Share by End User (2017-2017)

5.2.1.  Global Botulinum Toxin Sales and Sales Share by End User (2017-2017)

5.2.2.  Global Botulinum Toxin Revenue and Revenue Share by End User (2017-2017)

5.3.       The Botulinum Toxin Market   Assessment and Forecast, By End User, 2017-2023

5.4.       Aesthetic

5.4.1.  Market Assessment and Forecast, By Region, 2017-2023($Million)

5.5.       Therapeutics

5.5.1.  Market Assessment and Forecast, By Region, 2017-2023($Million)

6.       Botulinum Toxin Market, By Region

6.1.       Introduction

6.2.       Botulinum Toxin Market Assessment and Forecast, By Region, 2017-2023 ($Million)

6.3.       Global Botulinum Toxin Sales, Revenue and Market Share by Regions

6.3.1.  Global Botulinum Toxin Sales by Regions (2017-2017)

6.3.2.  Global Botulinum Toxin Revenue by Regions (2017-2017)

6.4.       North America

6.4.1.  North America Botulinum Toxin Sales and Growth Rate (2017-2017)

6.4.2.  Market Assessment and Forecast, By Country, 2017-2023($Million)

6.4.3.  Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.4.4.  Market Assessment and Forecast, By End User, 2017-2023($Million)

6.4.5.  U.S.

6.4.5.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.4.5.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.4.6.  Canada

6.4.6.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.4.6.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.4.7.  Mexico

6.4.7.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.4.7.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.5.       Europe

6.5.1.  Europe Botulinum Toxin Sales and Growth Rate (2017-2017)

6.5.2.  Market Assessment and Forecast, By Country, 2017-2023($Million)

6.5.3.  Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.5.4.  Market Assessment and Forecast, By End User, 2017-2023($Million)

6.5.5.  Germany

6.5.5.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.5.5.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.5.6.  France

6.5.6.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.5.6.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.5.7.  UK

6.5.7.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.5.7.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.5.8.  Italy

6.5.8.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.5.8.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.5.9.  Spain

6.5.9.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.5.9.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.5.10.      Rest of Europe

6.5.10.1. Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.5.10.2. Market Assessment and Forecast, By End User, 2017-2023($Million)

6.6.       Asia-Pacific

6.6.1.  Asia-Pacific Botulinum Toxin Sales and Growth Rate (2017-2017)

6.6.2.  Market Assessment and Forecast, By Country, 2017-2023($Million)

6.6.3.  Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.6.4.  Market Assessment and Forecast, By End User, 2017-2023($Million)

6.6.5.  Japan

6.6.5.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.6.5.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.6.6.  China

6.6.6.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.6.6.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.6.7.  Australia

6.6.7.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.6.7.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.6.8.  India

6.6.8.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.6.8.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.6.9.  South Korea

6.6.9.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.6.9.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.6.10.      Rest of Asia-Pacific

6.6.10.1. Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.6.10.2. Market Assessment and Forecast, By End User, 2017-2023($Million)

6.7.       Rest of the World

6.7.1.  Rest of the World Botulinum Toxin Sales and Growth Rate (2017-2017)

6.7.2.  Market Assessment and Forecast, By Country, 2017-2023($Million)

6.7.3.  Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.7.4.  Market Assessment and Forecast, By End User, 2017-2023($Million)

6.7.5.  Brazil

6.7.5.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.7.5.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.7.6.  Turkey

6.7.6.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.7.6.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.7.7.  Saudi Arabia

6.7.7.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.7.7.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.7.8.  South Africa

6.7.8.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.7.8.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.7.9.  United Arab Emirates

6.7.9.1.    Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.7.9.2.    Market Assessment and Forecast, By End User, 2017-2023($Million)

6.7.10.      Others

6.7.10.1. Market Assessment and Forecast, By Product Type, 2017-2023($Million)

6.7.10.2. Market Assessment and Forecast, By End User, 2017-2023($Million)

7.       Company Profiles

7.1.       Ipsen group

7.1.1.  Business Overview

7.1.2.  Product Portfolio

7.1.3.  Strategic Developments

7.1.4.  Botulinum Toxin Sales, Revenue and Market Share

7.2.       Allergan Inc.

7.2.1.  Business Overview

7.2.2.  Product Portfolio

7.2.3.  Strategic Developments

7.2.4.  Botulinum Toxin Sales, Revenue and Market Share

7.3.       Medytox Inc.

7.3.1.  Business Overview

7.3.2.  Product  Portfolio

7.3.3.  Strategic Developments

7.3.4.  Botulinum Toxin Sales, Revenue and Market Share

7.4.       Merz GmbH and Co. KGaA

7.4.1.  Business Overview

7.4.2.  Product Portfolio

7.4.3.  Strategic Developments

7.4.4.  Botulinum Toxin Sales, Revenue and Market Share

7.5.       US Worldmed, LLC

7.5.1.  Business Overview

7.5.2.  Product Portfolio

7.5.3.  Strategic Developments

7.5.4.  Botulinum Toxin Sales, Revenue and Market Share

7.6.       Lanzhou Institute of Biological Products Co. Ltd.

7.6.1.  Business Overview

7.6.2.  Product Portfolio

7.6.3.  Strategic Developments

7.6.4.  Botulinum Toxin Sales, Revenue and Market Share

7.7.       Revance Therapeutics, Inc.

7.7.1.  Business Overview

7.7.2.  Product Portfolio

7.7.3.  Strategic Developments

7.7.4.  Botulinum Toxin Sales, Revenue and Market Share

8.       Global Botulinum Toxin Market Competition, by Manufacturer

8.1.       Global Botulinum Toxin Sales and Market Share by Manufacturer (2017-2017)

8.2.       Global Botulinum Toxin Revenue and Market Share by Manufacturer (2017-2017)

8.3.       Top 5 Botulinum Toxin Manufacturer Market Share

8.4.       Market Competition Trend

---

List of Tables

Table: Global Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Global Botulinum Toxin Sales and Sales Share by Product Type (2017-2017)

Table: Global Botulinum Toxin Revenue and Revenue Share by Product Type (2017-2017)

Table: Botulinum Toxin Type A Market, By Region, 2017-2023($Million)

Table: Botulinum Toxin Type B Market, By Region, 2017-2023($Million)

Table: Global Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Global Botulinum Toxin Sales and Sales Share by End User (2017-2017)

Table: Global Botulinum Toxin Revenue and Revenue Share by End User (2017-2017)

Table: Aesthetic Market, By Region, 2017-2023($Million)

Table: Therapeutics Market, By Region, 2017-2023($Million)

Table: Global Botulinum Toxin Sales, Revenue and Market Share by Regions

Table: North America Botulinum Toxin Sales and Growth Rate (2017-2017)

Table: North America Botulinum Toxin Market, By Country, 2017-2023($Million)

Table: North America Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: North America Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: U.S. Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: U.S. Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Canada Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Canada Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Mexico Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Mexico Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Europe Botulinum Toxin Sales and Growth Rate (2017-2017)

Table: Europe Botulinum Toxin Market, By Country, 2017-2023($Million)

Table: Europe Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Europe Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Germany Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Germany Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: France Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: France Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: UK Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: UK Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Italy Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Italy Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Spain Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Spain Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Rest of Europe Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Rest of Europe Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Asia-Pacific Botulinum Toxin Sales and Growth Rate (2017-2017)

Table: Asia-Pacific Botulinum Toxin Market, By Country, 2017-2023($Million)

Table: Asia-Pacific Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Asia-Pacific Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Japan Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Japan Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: China Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: China Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Australia Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Australia Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: India Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: India Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: South Korea Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: South Korea Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Rest of Asia-Pacific Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Rest of Asia-Pacific Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Rest of the World Botulinum Toxin Sales and Growth Rate (2017-2017)

Table: Rest of the World Botulinum Toxin Market, By Country, 2017-2023($Million)

Table: Rest of the World Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Rest of the World Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Brazil Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Brazil Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Turkey Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Turkey Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Saudi Arabia Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Saudi Arabia Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: South Africa Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: South Africa Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: United Arab Emirates Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: United Arab Emirates Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Others Botulinum Toxin Market, By Product Type, 2017-2023($Million)

Table: Others Botulinum Toxin Market, By End User, 2017-2023($Million)

Table: Ipsen group: Key Strategic Developments, 2017-2017

Table: Allergan Inc.: Key Strategic Developments, 2017-2017

Table: Medytox Inc.: Key Strategic Developments, 2017-2017

Table: Merz GmbH and Co. KGaA: Key Strategic Developments, 2017-2017

Table: US Worldmed, LLC: Key Strategic Developments, 2017-2017

Table: Lanzhou Institute of Biological Products Co. Ltd.: Key Strategic Developments, 2017-2017

Table: Revance Therapeutics, Inc.: Key Strategic Developments, 2017-2017

---

List of Figures

Figure: Global Botulinum Toxin Market Share, By Product Type, 2017 & 2023

Figure: Global Botulinum Toxin Market, By End User, 2017 & 2023 ($Million)

Figure: Global Botulinum Toxin Market, By Region, 2017 & 2023 ($Million)

Figure: Global Botulinum Toxin Sales and Sales Share by Product Type (2017-2017)

Figure: Global Botulinum Toxin Revenue and Revenue Share by Product Type (2017-2017)

Figure: Global Botulinum Toxin Sales and Sales Share by End User (2017-2017)

Figure: Global Botulinum Toxin Revenue and Revenue Share by End User (2017-2017)

Figure: North America Botulinum Toxin Sales and Growth Rate (2017-2017)

Figure: Europe Botulinum Toxin Sales and Growth Rate (2017-2017)

Figure: Asia-Pacific Botulinum Toxin Sales and Growth Rate (2017-2017)

Figure: Rest of the World Botulinum Toxin Sales and Growth Rate (2017-2017)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country